Free Trial

Aspira Women's Health Q3 2023 Earnings Report

Aspira Women's Health logo
$0.09 -0.01 (-6.19%)
As of 04/4/2025 04:00 PM Eastern

Aspira Women's Health EPS Results

Actual EPS
-$0.48
Consensus EPS
-$0.43
Beat/Miss
Missed by -$0.05
One Year Ago EPS
N/A

Aspira Women's Health Revenue Results

Actual Revenue
$2.22 million
Expected Revenue
$2.90 million
Beat/Miss
Missed by -$680.00 thousand
YoY Revenue Growth
N/A

Aspira Women's Health Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Remove Ads

Aspira Women's Health Earnings Headlines

Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
See More Aspira Women's Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aspira Women's Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aspira Women's Health and other key companies, straight to your email.

About Aspira Women's Health

Aspira Women's Health (NASDAQ:AWH), Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

View Aspira Women's Health Profile

More Earnings Resources from MarketBeat